Publication:
Addressing beta-lactam allergy: A time for action.

dc.contributor.authorPhillips, Elizabeth J
dc.contributor.authorDemoly, Pascal
dc.contributor.authorTorres, Maria J
dc.contributor.funderNational Health and Medical Research Council of Australia
dc.date.accessioned2023-05-03T13:28:20Z
dc.date.available2023-05-03T13:28:20Z
dc.date.issued2021-09-22
dc.description.abstractIt is now 93 years since the discovery of penicillins, and over 75 yearssince the first use of penicillin. We have entered yet another wave ofchallenges plagued with antibiotic resistance accelerating at a ratethat well exceeds that of new antibiotic development. In the faceof these uphill battles, 8%–15% of a global population who has hadaccess to care is labeled as penicillin allergic.
dc.description.sponsorshipEJP reports grants from National Institutes of Health (P50GM115305,R01HG010863, R01AI152183, U01AI154659, UAI109565) andfrom the National Health and Medical Research Council of Australia.
dc.description.versionNo
dc.identifier.citationPhillips EJ, Demoly P, Torres MJ. Addressing beta-lactam allergy: A time for action. Allergy. 2022 Apr;77(4):1091-1093
dc.identifier.doi10.1111/all.15135
dc.identifier.essn1398-9995
dc.identifier.pmid35344217
dc.identifier.unpaywallURLhttps://doi.org/10.22541/au.163256850.05777844/v1
dc.identifier.urihttp://hdl.handle.net/10668/19892
dc.issue.number4
dc.journal.titleAllergy
dc.journal.titleabbreviationAllergy
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.organizationCentro Andaluz de Nanomedicina y Biotecnología-BIONAND
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number1091-1093
dc.provenanceRealizada la curación de contenido 09/08/2024
dc.publisherWiley
dc.pubmedtypeEditorial
dc.pubmedtypeResearch Support, N.I.H., Extramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDP50GM115305
dc.relation.projectIDR01HG010863
dc.relation.projectIDR01AI152183
dc.relation.projectIDU01AI154659
dc.relation.projectIDUAI109565
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/10.1111/all.15135
dc.rights.accessRightsopen access
dc.subjectAnti-bacterial agents
dc.subjectDrug hypersensitivity
dc.subjectAllergy
dc.subject.decsAntibacterianos
dc.subject.decsHipersensibilidad a las drogas
dc.subject.decsbeta-Lactamas
dc.subject.meshAnti-Bacterial agents
dc.subject.meshDrug hypersensitivity
dc.subject.meshHumans
dc.subject.meshbeta-lactams
dc.titleAddressing beta-lactam allergy: A time for action.
dc.typeresearch article
dc.type.hasVersionSMUR
dc.volume.number77
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format